NYSE:WAT - Waters Stock Price, Forecast & News

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Waters declared that its board has authorized a stock buyback program on Tuesday, April 24th 2018, which authorizes the company to buyback $3,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 18.2% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's leadership believes its shares are undervalued.

Waters Co. (NYSE:WAT) released its quarterly earnings data on Tuesday, February, 4th. The medical instruments supplier reported $3.20 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $3.01 by $0.19. The medical instruments supplier earned $716 million during the quarter, compared to analyst estimates of $714.34 million. Waters had a return on equity of 172.16% and a net margin of 24.61%. The company's revenue was up .1% on a year-over-year basis. During the same period in the prior year, the firm earned $2.87 earnings per share. View Waters' Earnings History.

Waters is scheduled to release their next quarterly earnings announcement on Tuesday, April 28th 2020. View Earnings Estimates for Waters.

Waters issued an update on its FY20 earnings guidance on Tuesday, February, 4th. The company provided earnings per share (EPS) guidance of $9.15-$9.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.80.

11 analysts have issued twelve-month price targets for Waters' stock. Their forecasts range from $177.00 to $230.00. On average, they anticipate Waters' stock price to reach $203.71 in the next twelve months. This suggests a possible upside of 0.5% from the stock's current price. View Analyst Price Targets for Waters.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 sell ratings and 5 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Waters.

Headlines about WAT stock have been trending extremely negative on Wednesday, according to InfoTrie. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Waters earned a news sentiment score of -5.0 on InfoTrie's scale. They also assigned press coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Waters.

Waters saw a decline in short interest in February. As of February 14th, there was short interest totalling 5,510,000 shares, a decline of 9.5% from the January 30th total of 6,090,000 shares. Based on an average daily trading volume, of 455,800 shares, the days-to-cover ratio is presently 12.1 days. Currently, 8.6% of the company's shares are short sold. View Waters' Current Options Chain.

Some companies that are related to Waters include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Charles River Laboratories Intl. (CRL), BIO-TECHNE (TECH), Bruker (BRKR), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Alibaba Group (BABA), Home Depot (HD), Honeywell International (HON), CVS Health (CVS), Procter & Gamble (PG), Raytheon (RTN), Verizon Communications (VZ), Cisco Systems (CSCO) and Northrop Grumman (NOC).

Waters' stock is owned by a number of of institutional and retail investors. Top institutional investors include Massachusetts Financial Services Co. MA (8.71%), Bank of New York Mellon Corp (7.14%), State Street Corp (4.50%), Baillie Gifford & Co. (3.68%), Janus Henderson Group PLC (2.55%) and Champlain Investment Partners LLC (1.55%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Institutional Ownership Trends for Waters.

WAT stock was sold by a variety of institutional investors in the last quarter, including Fenimore Asset Management Inc., FMR LLC, State Street Corp, Baillie Gifford & Co., Jensen Investment Management Inc., Pictet Asset Management Ltd., Triodos Investment Management BV and Trillium Asset Management LLC. Company insiders that have sold Waters company stock in the last year include Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Laurie H MD Glimcher, Mark T Beaudouin, Robert G Carson and Terrence P Kelly. View Insider Buying and Selling for Waters.

WAT stock was acquired by a variety of institutional investors in the last quarter, including Anchor Capital Advisors LLC, Amundi Pioneer Asset Management Inc., Man Group plc, Great West Life Assurance Co. Can, Credit Suisse AG, Mawer Investment Management Ltd., Bank of New York Mellon Corp and Massachusetts Financial Services Co. MA. View Insider Buying and Selling for Waters.

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of WAT stock can currently be purchased for approximately $202.60.

Waters has a market capitalization of $13.05 billion and generates $2.41 billion in revenue each year. The medical instruments supplier earns $592.20 million in net income (profit) each year or $8.99 on an earnings per share basis. Waters employs 7,200 workers across the globe.View Additional Information About Waters.

The official website for Waters is http://www.waters.com/.

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]